NHS National Generic Pharmaceuticals - Lenalidomide
Invitation to offer for NHS National Generic Pharmaceuticals - Lenalidomide Offer reference number: CM/PHG/21/5638 Period of framework agreement: 01/09/2022 to 31/08/2023 (12 months) with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Lenalidomide: ALL REGIONS: 01/09/2022 to 31/08/2023 (12 months)
Buyer
NHS England
Value
£1
Published
30 Sept 2022
Closes
18 Jul 2022
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Other
Category
Goods
Contract starts
31 Aug 2022
Contract ends
31 Aug 2023
CPV classifications
33600000
Pharmaceutical products
Lots
Lot default NHS National Generic Pharmaceuticals - Lenalidomide
£26,345,313
Invitation to offer for NHS National Generic Pharmaceuticals - Lenalidomide Offer reference number: CM/PHG/21/5638 Period of framework agreement: 01/09/2022 to 31/08/2023 (12 months) with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreem...
Delivery: East Midlands · United Kingdom, East of England · United Kingdom, Guernsey, Isle of Man, Jersey, London · United Kingdom
Documents
Unlock document linkAwarded contract notice on Contracts Finder
30 Sept 2022
Awarded contract notice on Contracts Finder
Award notice · Web page
Transparency Award Schedule - Sandoz Limited
Not provided
Transparency Award Schedule - Sandoz Limited
Transparency Award Schedule - Bristol Myers Squibb Pharmaceutical Limited
Not provided
Transparency Award Schedule - Bristol Myers Squibb Pharmaceutical Limited
Transparency Award Schedule - Piramal Critical Care Limited
Not provided
Transparency Award Schedule - Piramal Critical Care Limited
Document No. 03 - Framework Agreement and Terms and Conditions - Lenalidomide
Not provided
Document No. 03 - Framework Agreement and Terms and Conditions - Lenalidomide
Parties appointed to the Framework Agreement & SME status - Lenalidomide
Not provided
Parties appointed to the Framework Agreement & SME status - Lenalidomide
Excel spreadsheet
Transparency Award Schedule - Zentiva Pharma UK Ltd
Not provided
Transparency Award Schedule - Zentiva Pharma UK Ltd
Transparency Award Schedule - Accord-UK Ltd
Not provided
Transparency Award Schedule - Accord-UK Ltd
Transparency Award Schedule - Amarox Limited
Not provided
Transparency Award Schedule - Amarox Limited
Transparency Award Schedule - Glenmark Pharmaceuticals Europe Limited
Not provided
Transparency Award Schedule - Glenmark Pharmaceuticals Europe Limited
Transparency Award Schedule - Mercury Pharmaceuticals Limited
Not provided
Transparency Award Schedule - Mercury Pharmaceuticals Limited
Transparency Award Schedule - Morningside Pharmaceuticals Ltd
Not provided
Transparency Award Schedule - Morningside Pharmaceuticals Ltd
Contains public sector information licensed under the Open Government Licence v3.0.